VB100 Announces '2017 Future Healthcare 100' List and Presents Multiple Annual Awards

December 15–17, 2017: VCBeat’s “Top 100 Future Healthcare Companies 2017” Forum was held at the Beijing Marriott Hotel. On the evening of December 15, VCBeat announced the China List and Overseas List of the “Top 100 Future Healthcare Companies 2017,” along with key awards including Listed Company of the Year for Driving Industry Progress, Innovative Company of the Year, High-Potential Company of the Year, Investment Firm of the Year, and Best Investor of the Year, targeting the healthcare industry.

Award-Winning Enterprises' Plaque Wall

In this era of rapid change and immense challenges, the healthcare industry is undergoing profound transformations. How can we comprehend this era and gain insight into the patterns of industrial evolution?

VCBeat uses innovation and growth potential as its benchmarks to map out this era of dynamic change. The “Top 100 Future Healthcare Companies” list aims to identify the most innovative and valuable startups and ventures in the healthcare sector.

In 2017, the “Top 100 Future Healthcare Companies” list built upon the previous year’s industry selection by introducing public voting and expert scoring mechanisms to identify the most representative high-potential enterprises across various healthcare subsectors. The initiative aims to set benchmarks for innovative companies, provide guidance for investment institutions, and deliver value to its audience.

The 2017 “Top 100 Future Healthcare Companies” list is as follows:

[Important Correction] According to official verification, Renhe Future completed its financing in July 2017, with a post-money valuation of RMB 2.75 billion.

The following is the list of overseas companies in the 2017 “Top 100 Future Healthcare Companies”:

VCBeat’s “2017 Report on the Competitiveness of the Future Healthcare Industry” points out that the healthcare industry is undergoing an era of “species explosion,” with accelerated transformation of the healthcare service system, capital-driven deep evolution of medical technologies, shifting patterns in traffic entry points, and increasing cross-industry integration...

Driven by a confluence of factors, a cohort of high-profile enterprises has emerged across various niche sectors of medical innovation. Whether they are traditional companies committed to bold transformation or startups forging ahead with determination, these entities have become the most influential voices in the healthcare innovation landscape.

The 2017 Annual Awards of the “Future Healthcare Top 100” were determined through voting by a publicly selected panel of judges comprising industry experts, investors, and entrepreneurial practitioners. The final selections were jointly made by the VCBeat Content Center, VBInsight, and the industry judging panel. The awards featured three major categories—“Innovative Enterprises,” “Investment,” and “Industry Chain”—and included several prestigious annual honors such as “Listed Company of the Year for Driving Force,” “Innovative Enterprise of the Year,” “Most Promising Enterprise of the Year,” “Investment Firm of the Year,” and “Best Investor of the Year.”

[Annual Driving Force Listed Company]

Berry Genomics, Yuheng Pharmaceutical, Meinian Onehealth, Tasly, Fosun Pharma, Aier Eye Hospital, Zhenghai Biotechnology, KingMed Diagnostics, Yixintang, Chuangye Software

[Annual Innovative Enterprise]

Miao Health,Remote Vision,Medlinker,Yitu Technologies,Zero Krypton Technology,WeDoctor,Anhan Medical,3D Medicines,Haodf Online,Xiaodoumiao

[Annual Potential Enterprise]

Medical Imaging:Yasen Technology, Deepwise Medical;Hospital Management:Yi Man Yi;Innovative Medical Services:Wei Ai Kang;Health Management:Kangbairui, Penguin Doctor;Medical Artificial Intelligence:Boshi Medical Cloud, XtalPi;Blockchain:Renji Health;Medical Insurance Cost Control:Shulian Yikang;IoT:Dao Yi Xun;Genes:Yuce Bio;Innovative Medical Devices:Juding Medical;Medical Aesthetics:Billionaire;Pharmaceutical Distribution:Kuaifang Medicine Delivery;Mental Health:Good Mood.

[Annual Investment Institution]

Sequoia Capital,Legend Capital,Qiming Venture Partners,Legend Star,Fortune Capital,GTJA Investment,VCBeat Investment,Yueyin Healthcare Fund,Huayi Capital,Huagai Capital

[Best Investor of the Year]

Legend Capital - Daqing Cai,Sequoia Capital - Lu Qinchao,Huagai Capital - Xu Xiaolin,SoftBank China - Wu Kai,Zhongwei Fund - Li Wengang, Yuanyi Capital - Gao Yi

Below are the winners of the annual awards for the “Future Healthcare Top 100”:

Embracing Disarray: Decentralized Historical Transformation and Rediscovering the Value and Significance of Information Amidst Chaos. VCBeat will remain true to its original mission, advocating for the industry, supporting entrepreneurs in their growth, and delivering the most valuable industrial and content services to the sector.